Par Pharmaceutical Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Par Pharmaceutical Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Par Pharmaceutical Inc.

Par Pharmaceutical Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by OMEGA-3-ACID ETHYL ESTERS. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: ethyl esters, omega- acid, capsules usp, indicated adjunct, diet reduce, triglyceride levels, adult patients, severe hypertriglyceridemia. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
OMEGA-3-ACID ETHYL ESTERS 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Par Pharmaceutical Inc.

Brand nameGenericTypeRoute
Omega-3-acid ethyl esters OMEGA-3-ACID ETHYL ESTERS HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Par Pharmaceutical Inc. make?
1 FDA drug label records name Par Pharmaceutical Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Par Pharmaceutical Inc. produce?
The most frequent active ingredients in this portfolio are OMEGA-3-ACID ETHYL ESTERS.

Are Par Pharmaceutical Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.